drugset / Trial / NCT00054015
3-AP in Treating Patients With Advanced Prostate Cancer
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of 3-AP in treating patients who have advanced prostate cancer that has been previously treated with hormone therapy.
Timeline
- Start
- 2002-12
- Primary completion
- —
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triapine | Small molecule | — | Intravenous |